Diphenylprolinol
Diphenylprolinol (D2PM), or (R/S)-(±)-diphenyl-2-pyrrolidinyl-methanol, is a norepinephrine-dopamine reuptake inhibitor which is used as a designer drug.[1][2]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.118.791 |
Chemical and physical data | |
Formula | C17H19NO |
Molar mass | 253.345 g·mol−1 |
3D model (JSmol) | |
| |
| |
|
Pharmacology
The dextrorotary (R)-(+)-enantiomer is the most pharmacologically active, although a variety of related derivatives have been studied.[3]
Side effects including chest pain (suggestive of possible cardiovascular toxicity) have been seen following recreational use of diphenylprolinol, although it was combined with glaucine in a party pill product, thus making it impossible to say for certain which drug was responsible.[4]
Other uses
Diphenylprolinol can be used to prepare the chiral CBS catalyst, which is used for enantioselective organic synthesis.[5]
gollark: Anyway, I don't have the compute available to do this sort of thing *regularly*.
gollark: That's probably too slow.
gollark: (newlines are because I am copypasting it out of a terminal)
gollark: Further output:> that would be a bit cheaty, but I suppose it could be done.<|endoftext|>I don't know exactly what it was going to involve, but I'm pretty sure it'd be a bit cheaty anyway.<|endoftext|>And there's probably a guide to do that, but I don't know exactly what I'm doing about that is doing it.<|endoftext|>I can't actually read the summary, though.<|endoftext|>No, it's on the roadmap though.<|endoftext|>The next update:> your code is binding and has some bits which aren't signed into my account.<|endoftext|>Not really. It's not going to be hard to make a userscript for it.<|endoftext|>You could also do that.<|endoftext|>It's not a forum thing here.<|endoftext|>The guide's up to the ones below the GDPR, which is neat.<|endoftext|>I'm working on a link-type guide to the actual forum, or something.<|endoftext|>They can't really do much testing, though, though, so you could
gollark: I know, right?
See also
- 2-Diphenylmethylpyrrolidine (Desoxy-diphenylprolinol)
- Desoxypipradrol
- Pipradrol
- Prolinol
- Corey-Bakshi-Shibata reduction
References
- Wood DM, et al. (2008). "Detection of the novel recreational drug Diphenyl-2-pyrrolidinemethanol (D2PM) sold legally in combination with 1-Benzylpiperzaine (BZP)". Clinical Toxicology. 46: 393. doi:10.1080/15563650802071703. PMID 18568796.
- Davies S. Drug Trends and New Designer Drugs. St George's University of London. 6 November 2008.
- US patent 5925666, Paul F. Jackson et al., "Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives"
- Lidder, S; Dargan, P; Sexton, M; Button, J; Ramsey, J; Holt, D; Wood, D (2008). "Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol D2PM)". Journal of Medical Toxicology. 4 (3): 167–9. doi:10.1007/bf03161195. PMC 3550040. PMID 18821489.
- Corey, E. J.; Bakshi, R. K.; Shibata S. (1987). "Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines Mechanism and synthetic implications". J. Am. Chem. Soc. 109 (18): 5551–5553. doi:10.1021/ja00252a056. ISSN 0002-7863.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.